Noetik

About Noetik

Noetik is an AI-native biotechnology company focused on leveraging advanced machine learning to discover and develop precision cancer therapies. Their mission is to redefine cancer treatment by capturing the complexity of tumor-immune interactions and building foundation models for cell and tissue biology, starting with the patient as the best model system.

Products & Services

Precision Cancer Therapies: Developing targeted cancer treatments using self-supervised learning and multimodal human data to drive therapeutic development.

Specialties

AI and Machine Learning Self-Supervised Learning Cancer Therapy Development Multimodal Human Data Analysis Cell and Tissue Biology Modeling

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 40000000 MR: - FA: $40 million FAN: 40000000	D: 2024-08-29 FD: 2024-08-29	13 investors
2	RT: Seed T: - FT: Seed	A: 14000000 MR: - FA: $14 Million FAN: 14000000	D: 2023-09-07 FD: 2023-09-07	13 investors

Series A Latest

2024-08-29

$40.0M

13 investors (Pro only)

Seed 2023-09-07

$14.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James Hardiman

Board Director

A

Amy Schulman

Board Member

R

Ron W. Alfa

Co-Founder, CEO

M

Matthew Albert

Board Member

D

Dylan Reid

Board Observer

M

Manik Kuchroo

Board Observer

View 44 more team members with Pro

Unlock Full Team Directory

Recent News

Noetik Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised